ALPACA IEX stock feed
US-LISTED SECTOR ETF · PRICE PROXY
Health care
XLV · IEX stock feed · observed Oct 16, 2026, 3:59 PM EDT
$176.66-0.28% TODAY
PRICE READ
Health care fell 0.28% from its previous close and outperformed SPY by 0.81 percentage points today. This describes ETF price movement, not every company in the sector.
90-SESSION RANGE$147.57–$178.85POSITION IN RANGE93% from low to high
RELATIVE PERFORMANCE
XLV compared with SPY.
Both series begin at 100. This makes direction comparable; it does not make the prices equal.
2026-06-10
XLVSPY
2026-10-16SCENARIO MONITOR · NOT A PRICE FORECAST
What would change the outlook?
A mechanical comparison of XLV with SPY. It describes evidence and disconfirmers instead of predicting a target price.
XLV is leading SPY across the current mix of today, 5-, 30-, and 90-session comparisons. 3 of 3 longer windows are ahead of SPY. This is a trend description, not a price forecast.
The signal would strengthen if XLV leads SPY across both short and longer windows while the next official releases support the sector’s operating backdrop.
The signal would weaken if relative performance turns negative across the 30- and 90-session windows or upcoming public data challenges the sector narrative.
Federal Reserve rate decision · Federal Reserve
WHY THIS MAY BE MOVING
Relevant evidence—not a claim of cause.
These public facts provide context. They do not prove why traders changed the ETF price.
Jobs and household prices
Consumer prices changed 3.7% from a year earlier. Unemployment was 4.2%. Employment and inflation provide broad demand context, but they do not explain health-care stocks on their own.
3.7% inflationBLS Public Data API · September 2026 ↗Borrowing-cost backdrop
The official 10-year Treasury rate was 5.09%. The 2-year rate was 4.74%, a 0.35-point gap. Interest rates can affect company valuations and financing costs across health care.
5.09%Treasury daily yield curve · 2026-10-16 ↗NEXT ON THE CLOCK
Official releases that could matter.
Scheduled public information—not a prediction that the sector will move.
Federal ReserveOct 28, 11:00 AM MST · Arizona
high
Federal Reserve rate decision
Rate decisions affect financing costs and the value investors place on future earnings.
Federal Reserve meeting calendar ↗IN11d 4h
BEAOct 29, 5:30 AM MST · Arizona
high
First estimate of third-quarter GDP
Growth and consumer spending help frame demand across the broader economy.
BEA release schedule ↗IN11d 22h
BLSNov 6, 6:30 AM MST · Arizona
high
October jobs report
Jobs and prices provide broad context for household coverage, labor costs, and medical spending.
BLS employment release schedule ↗IN19d 23h
BLSNov 10, 6:30 AM MST · Arizona
high
October consumer prices
Jobs and prices provide broad context for household coverage, labor costs, and medical spending.
BLS 2026 release calendar ↗IN23d 23h
Dates and times come from the linked agencies and can change. Signal Desk shows relevance, not causation, consensus, or a trading instruction.
COMPANY HOMEWORK QUEUE
Six companies to research—not six recommendations.
Three established leaders and three smaller, newer, or higher-volatility stories. Open a company to reach its SEC filings and homework checklist.
ESTABLISHEDLLY
Eli Lilly
Global pharmaceuticals
WATCH · Obesity-drug demand, manufacturing capacity, pipeline, and pricingPRIMARY RISK · Concentration, competition, and clinical or policy setbacksESTABLISHEDUNH
UnitedHealth Group
Health insurance and care services
WATCH · Medical-cost trend, enrollment, Optum growth, and cash flowPRIMARY RISK · Reimbursement, regulation, medical costs, and executionESTABLISHEDJNJ
Johnson & Johnson
Pharmaceuticals and medical technology
WATCH · Product growth, pipeline, medtech demand, and litigationPRIMARY RISK · Patent losses, trials, litigation, and regulationEMERGING / HIGHER RISKRXRX
Recursion Pharmaceuticals
AI-enabled drug discovery
WATCH · Clinical milestones, partnerships, cash runway, and platform validationPRIMARY RISK · Early-stage science, dilution, and uncertain commercializationEMERGING / HIGHER RISKTEM
Tempus AI
Clinical data, diagnostics, and health-care AI
WATCH · Data revenue, testing volume, margins, and cash usePRIMARY RISK · Young public record, reimbursement, privacy, and valuationEMERGING / HIGHER RISKCRSP
CRISPR Therapeutics
Gene-editing therapies
WATCH · Commercial launch, clinical readouts, partnerships, and cash runwayPRIMARY RISK · Clinical, regulatory, manufacturing, and dilution riskXLV is a traded ETF used as a stand-in for the health care sector. Its holdings, weights, fees, and IEX observations are not the same as every company in the sector or a consolidated full-market index. This page is informational and is not a recommendation.